tumour
necrosi
shown
play
role
mani
inflammatori
condit
current
drug
eg
etanercept
use
human
treatment
autoimmun
diseas
studi
aim
elucid
role
develop
virusendotoxininduc
respiratori
diseas
twentytwo
caesarean
deriv
colostrum
depriv
pig
use
initi
avail
lung
circul
possibl
clinic
inflammatori
effect
etanercept
alon
assess
pig
intratrach
intraperiton
administr
mgper
routep
pig
high
activ
detect
bronchoalveolar
lavag
bal
fluid
periton
lavag
fluid
serum
anim
least
h
postinocul
hpi
clinic
symptom
lung
lesion
lung
cell
infiltr
induct
bal
detect
subsequ
abil
etanercept
block
porcin
effect
mention
paramet
lung
viru
titr
assess
pig
inocul
intratrach
porcin
respiratori
coronaviru
prcv
follow
lipopolysaccharid
lp
h
later
etanercept
administ
time
lp
inocul
via
rout
dose
initi
experi
paramet
compar
control
group
n
receiv
prcvlp
half
anim
group
euthan
rest
h
lp
inocul
complet
neutral
anim
euthan
hpi
significantli
lower
prcvlp
group
time
signific
differ
diseas
sever
lung
lesion
viru
replic
lung
cell
infiltr
level
observ
two
group
block
alon
suffici
amelior
diseas
prcvlp
model
respiratori
diseas
possibl
due
redund
proinflammatori
cytokin
cascad
involv
unidentifi
diseas
mediat
tumor
necrosi
proinflammatori
cytokin
secret
mani
cell
type
earliest
stage
inflamm
essenti
factor
mediat
immun
respons
infect
howev
also
play
import
role
induct
septic
shock
autoimmun
diseas
rheumatoid
arthriti
diabet
becom
major
therapeut
target
treatment
mani
cutan
system
inflammatori
diseas
moder
sever
psoriasi
psoriat
arthriti
rheumatoid
arthriti
ankylos
spondyl
crohn
diseas
juvenil
rheumatoid
arthriti
ulcer
coliti
review
jackson
current
exist
drug
use
inhibit
patholog
human
base
differ
mechan
action
natur
exist
tnfreceptor
bind
tnf
mediat
biolog
activ
etanercept
recombin
monoclon
antibodi
infliximab
adalimumab
bind
neutral
specif
human
etanercept
repres
fusion
protein
consist
extracellular
ligandbind
portion
human
kda
tnfreceptor
tnfr
link
fc
portion
human
antibodi
see
http
wwwenbrelcomprescribinginformationjsp
access
august
thu
bind
solubl
activ
form
membran
bound
inact
form
render
biolog
inact
adalimumab
infliximab
hand
bind
specif
solubl
membran
bound
review
jackson
human
suspect
play
also
signific
role
differ
complex
lung
inflammatori
condit
asthma
acut
respiratori
distress
syndrom
ard
chronic
obstruct
pulmonari
diseas
copd
review
mukhopadhyay
et
al
howev
role
clear
yet
aetiolog
mention
respiratori
condit
complex
well
understood
previous
develop
reproduc
model
sever
acut
respiratori
diseas
pig
inocul
intratrach
porcin
respiratori
coronaviru
prcv
h
later
bacteri
lipopolysaccharid
lp
van
reeth
et
al
studi
van
reeth
et
al
assum
potenti
culprit
observ
clinic
synergi
sinc
tempor
associ
observ
peak
clinic
symptom
high
fever
depress
breath
difficulti
product
proinflammatori
cytokin
particular
lung
dualli
inocul
anim
contrast
pig
inocul
prcv
lp
exhibit
promin
respiratori
symptom
minim
cytokin
product
lung
current
studi
aim
elucid
role
prcvlp
model
respiratori
diseas
block
lung
prcvlp
inocul
pig
belgian
isol
prcv
use
second
passag
swine
testi
st
cell
van
reeth
pensaert
inocul
dose
tissu
cultur
infect
dose
tcid
per
pig
escherichia
coli
lp
difco
laboratori
sigma
use
dose
gkg
bodi
weight
dose
base
data
previou
studi
select
caus
mild
respiratori
sign
van
reeth
et
al
labarqu
et
al
enbrel
purchas
wyeth
pharmaceut
lyophil
product
contain
mg
etanercept
per
packag
dissolv
accord
manufactur
instruct
ml
pyrogenfre
ultra
pure
water
product
dissolv
phosphat
buffer
salin
pb
nonpyrogen
inocul
syring
contain
mg
etanercept
total
volum
ml
dose
enbrel
determin
basi
data
obtain
previou
experi
use
prcv
lp
model
respiratori
diseas
pig
preliminari
vitro
experi
abil
enbrel
neutralis
porcin
induc
cytotox
bioassay
use
subclon
cell
dose
calcul
abl
complet
neutral
activ
lung
within
first
h
lp
inocul
experi
caesarean
deriv
colostrum
depriv
piglet
origin
sow
use
pig
hous
individu
steril
condit
horsefalltyp
isol
unit
positivepressur
ventil
fed
commerci
ultrahightemperaturetr
cow
milk
anim
use
age
week
initi
experi
pig
receiv
mgpig
enbrel
intratrach
mgpig
intraperiton
serv
control
avail
side
effect
enbrel
alon
examin
paramet
enbrelonli
group
two
addit
pig
mockinocul
pyrogenfre
pb
intratrach
intraperiton
serv
neg
control
mockinocul
control
group
remain
pig
randomli
alloc
group
anim
group
inocul
intratrach
tcid
prcv
per
pig
h
later
lp
dose
gkg
bodi
weight
one
group
receiv
mgpig
enbrel
intratrach
syring
lp
mgpig
intraperiton
time
lp
inocul
prcvlpsenbrel
group
group
receiv
enbrel
serv
posit
control
prcvlp
group
half
anim
mention
group
euthan
h
last
inocul
hpi
rest
hpi
intratrach
inocul
perform
describ
previous
van
gucht
et
al
intraperiton
inject
perform
lower
part
abdomen
later
midlin
shallow
angl
concurr
aspir
confirm
needl
periton
caviti
urinari
bladder
intestin
lumen
intratrach
intraperiton
inject
done
volum
ml
inoculumpigrout
euthanasia
lung
remov
thorac
caviti
right
lung
use
lung
lavag
collect
concentr
bronchoalveolar
lavag
bal
fluid
balcel
analysi
perform
describ
previous
van
gucht
et
al
tissu
sampl
apic
cardiac
diaphragmat
lobe
left
lung
collect
virolog
bacteriolog
histopatholog
examin
serum
pig
also
collect
euthanasia
periton
caviti
anim
mockinocul
control
group
enbrelonli
group
flush
ml
pb
periton
fluid
collect
cytokin
examin
detect
residu
antitnf
activ
anim
experi
describ
studi
author
supervis
ethic
anim
welfar
committe
faculti
veterinari
medicin
ghent
univers
anim
monitor
least
time
per
day
beforeand
everi
h
last
inocul
score
given
respiratori
rate
per
minut
mild
tachypnoea
sever
tachypnoea
abdomin
thump
absent
present
dyspnoea
absent
present
anorexia
absent
present
depress
absent
present
occasion
anorexia
accompani
vomit
score
separ
total
score
per
pig
obtain
ad
score
paramet
rang
gross
lung
lesion
drawn
accur
possibl
onto
lung
diagram
percentag
affect
dorsal
ventral
lung
surfac
area
arbitrarili
assess
percentag
pulmonari
lesion
calcul
averag
approxim
percentag
dorsal
ventral
lung
surfac
area
exhibit
evid
tissu
consolid
quantifi
bioassay
describ
elsewher
hell
et
al
van
reeth
et
al
laboratori
standard
run
bioassay
sampl
test
individu
bioassay
geometr
mean
calcul
measur
duoset
elisa
kit
detect
common
subunit
r
system
abingdon
uk
sinc
bind
also
common
receptor
chain
similar
proinflammatori
activ
novelli
casanova
watford
et
al
review
basto
et
al
discrimin
detect
limit
cytokin
bioassay
uml
detect
limit
elisa
pgml
elisa
perform
accord
instruct
manufactur
quantifi
residu
antitnf
activ
collect
sampl
develop
bioassay
base
cytotox
assay
describ
earlier
van
reeth
et
al
briefli
pk
subclon
cell
seed
cultur
plate
cultur
confluenc
start
assay
cell
pretreat
h
c
transcript
inhibitor
actinomycin
becom
sensit
effect
meanwhil
twofold
dilut
examin
sampl
mix
u
laboratori
standard
solut
recombin
porcin
h
c
allow
residu
etanercept
sampl
bind
standard
neutral
activ
cellsensitis
pretreat
sampl
dilut
brought
cell
incub
h
c
degre
cytotox
measur
via
stain
crystal
violet
solut
wash
dissolv
acet
acid
optic
densiti
sampl
dilut
measur
nm
wave
length
use
elisa
reader
titr
enbrel
neutral
unit
nu
determin
revers
dilut
effect
standard
neutral
detect
limit
assay
numl
sampl
test
least
time
geometr
mean
calcul
intern
control
run
test
prcv
quantifi
lung
tissu
homogen
pool
sampl
apic
cardiac
diaphragmat
lung
lobe
viru
titr
determin
titrat
st
cell
accord
standard
procedur
van
reeth
pensaert
detect
limit
assay
tcid
g
tissu
viru
titr
calcul
use
method
reed
muench
reed
muench
routin
bacteriolog
examin
lung
tissu
perform
describ
earlier
van
gucht
et
al
histopatholog
examin
sampl
left
cardiac
diaphragmat
lung
lobe
fix
neutral
buffer
formalin
embed
paraffin
section
stain
haematoxylin
eosin
section
evalu
visual
three
criteria
alveolar
damag
appar
thicken
alveolar
septa
compar
neg
control
infiltr
inflammatori
cell
alveoli
alveolar
septa
standard
twosampl
mannwhitney
test
use
compar
valu
examin
paramet
differ
group
pig
p
valu
consid
signific
graphpad
prism
softwar
use
statist
analysi
enbrelonli
inocul
anim
show
strong
activ
examin
sampl
highest
level
hpi
bal
fluid
serum
hpi
periton
fluid
respect
see
tabl
activ
detect
examin
sampl
mockinocul
pig
detect
mockinocul
anim
enbrelonli
inocul
anim
examin
compart
titr
bal
fluid
prcvlp
inocul
pig
rang
uml
signific
differ
observ
pig
euthan
hpi
p
contrast
level
prcvlpsenbrel
group
significantli
lower
prcvlp
group
p
titr
gener
lower
hpi
though
differ
signific
p
see
fig
gener
enbrel
abl
complet
neutral
lung
anim
hpi
hpi
detect
pig
averag
titr
still
lower
prcvlp
group
macroscop
lung
lesion
observ
mockinocul
enbrelonli
inocul
anim
macroscop
lungles
score
prcvlp
prcvlpsenbrel
inocul
pig
given
tabl
prcvlp
inocul
pig
small
lesion
cover
total
lung
surfac
area
prcvlpsenbrel
group
anim
lesion
similar
prcvlp
group
cover
lung
surfac
p
gener
enbrel
seem
affect
develop
gross
lung
lesion
prcvlpsinocul
pig
first
h
administr
total
balcel
count
mockinocul
control
anim
rang
neutrophil
compris
less
cell
enbrelonli
treat
group
total
bal
cell
rang
low
level
max
neutrophil
detect
anim
euthan
hpi
see
tabl
total
bal
cell
percent
neutrophil
lung
prcvlpsenbrel
prcvlp
group
higher
mock
enbrelonli
inocul
group
p
see
tabl
signific
differ
cellinfiltr
paramet
two
inocul
group
p
diseas
symptom
observ
time
postinocul
pb
enbrel
alon
evolut
clinic
score
prcvlp
prcvlpsenbrel
group
shown
fig
prcvlp
treat
pig
show
similar
symptom
previou
experi
van
reeth
et
al
van
gucht
et
al
time
lp
inocul
anim
still
asymptomat
except
two
anim
display
mild
depress
tachypnoea
h
pig
develop
mark
tachypnoea
accompani
abdomin
thump
dyspnoea
depress
anorexia
vomit
also
observ
remain
pig
develop
milder
short
last
symptom
consist
depress
anorexia
mild
tachypnoea
hpi
symptom
resolv
complet
remain
pig
prcvlpsenbrel
treat
group
one
anim
show
mild
depress
time
lp
inocul
hpi
four
anim
develop
similar
symptom
prcvlp
group
tachypnoea
dyspnoea
andor
abdomin
thump
depress
andor
anorexia
vomit
anoth
pig
start
show
symptom
hpi
signific
differ
number
affect
anim
sever
clinic
symptom
prcvlp
prcvlpsenbrel
group
p
titr
bal
fluid
fig
compar
level
prcvlp
prcvlpsenbrel
group
mockinocul
enbrelonli
inocul
anim
detect
level
low
level
uml
respect
contrast
high
level
cytokin
detect
prcvlp
prcvlpsenbrel
group
signific
differ
two
group
anim
euthan
hpi
group
p
viru
detect
mockinocul
pig
enbrelonli
treat
pig
viru
titr
lung
prcvlpsenbrel
prcvlp
group
similar
p
rang
log
tcid
g
tissu
log
tcid
g
tissu
respect
fig
compar
common
histopatholog
find
observ
inocul
group
lesion
observ
either
mockor
enbrelonli
inocul
control
group
typic
prcvlesion
manifest
massiv
cell
infiltr
thicken
interalveolar
septa
collaps
alveoli
observ
lesionaffect
area
lung
prcvlp
prcvlpsenbrel
inocul
anim
histopatholog
find
similar
prcvlp
prcvlpsenbrel
group
studi
aim
elucid
role
develop
clinic
symptom
virusendotoxininduc
respiratori
diseas
well
establish
reproduc
model
diseas
prcvlp
inocul
pig
administ
intratrach
time
lp
inocul
enbrel
abl
success
block
porcin
produc
lung
knowledg
first
vivo
studi
show
direct
block
lung
pig
etanercept
enbrel
anoth
agent
infliximab
remicad
shown
effect
attenu
decreas
myocardi
function
cardiac
arrest
simul
coronari
occlus
pig
though
plasma
level
infliximabtr
mockinocul
anim
differ
significantli
measur
mean
elisa
niemann
et
al
differ
result
may
partial
explain
differ
mechan
function
biochem
natur
infliximab
see
http
wwwrxlistcomremicadedrug
htm
cp
access
august
etanercept
see
http
wwwenbrelcomprescribinginformationjsp
access
august
etanercept
previous
shown
reduc
endotoxininduc
pulmonari
hypertens
pig
mutschler
et
al
level
lung
determin
studi
moreov
clinic
symptom
also
determin
sinc
anim
inhal
anaesthesia
experi
success
block
etanercept
far
document
laboratori
anim
like
rat
di
paola
et
al
zhang
et
al
mice
fri
et
al
though
biolog
activ
determin
mention
studi
comparison
data
result
studi
howev
difficult
use
differ
measur
techniqu
western
blotanalysi
immunohistochemistri
tissu
di
paola
et
al
elisa
fri
et
al
zhang
et
al
also
differ
anim
model
diseas
model
rout
administr
etanercept
studi
zhang
et
al
level
bal
fluid
differ
etanercepttr
shamtreat
group
although
serum
block
differ
partial
explain
fact
subcutan
administr
etanercept
may
fail
result
suffici
concentr
drug
lung
pneumonia
cytokin
produc
local
site
infect
review
schultz
et
al
previou
studi
laboratori
also
notic
product
prcvlpsinduc
lung
inflamm
remain
local
minim
detect
serum
observ
unpublish
data
howev
make
sure
system
interfer
observ
clinic
symptom
administ
etanercept
also
intraperiton
high
residu
activ
detect
serum
enbrelonli
inocul
group
comparison
mockinocul
group
confirm
avail
enbrel
circul
data
suggest
block
amelior
clinic
symptom
prcvlp
model
sinc
observ
signific
differ
prcvlp
prcvlpsenbrel
inocul
group
mani
contradict
report
effect
therapi
diseas
sever
outcom
human
therapi
shown
also
littl
benefici
effect
pulmonari
diseas
though
anim
model
shown
variou
level
success
review
mukhopadhyay
et
al
criteria
clinic
examin
howev
differ
differ
studi
therefor
correct
comparison
usual
possibl
physiolog
pig
similar
human
anim
model
mice
rat
therefor
pig
research
becom
increasingli
import
viru
replic
histopatholog
find
macroscop
lung
lesion
also
differ
notabl
prcvlp
prcvlpsenbrel
group
apart
singl
pig
high
microscop
lungles
score
partial
accord
studi
peper
van
campen
administ
rabbit
antimous
antibodi
intraperiton
influenza
infect
mice
saw
effect
viru
replic
gross
histolog
lung
lesion
amelior
mention
studi
rat
zhang
et
al
also
reduct
sever
lung
histopatholog
lesion
observ
etanercept
treatment
model
howev
examin
earli
stage
infect
possibl
effect
lesion
develop
later
stage
exclud
studi
observ
signific
effect
etanercept
administr
neutrophil
infiltr
level
bal
fluid
prcvlp
inocul
pig
contrast
recent
studi
anim
model
exampl
studi
effect
intraperiton
administr
etanercept
ventilatorinduc
lung
injuri
mice
wolthui
et
al
observ
attenu
neutrophil
influx
signific
reduct
pulmonari
level
keratinocyt
chemoattract
etanercepttr
anim
versu
placebo
though
block
measur
group
mention
studi
zhang
et
al
reduc
neutrophil
infiltr
etanercept
administr
passiv
smoke
rat
also
observ
mark
reduct
local
mucos
neutrophil
infiltr
mice
ulcer
coliti
popivanova
et
al
rat
periodont
di
paola
et
al
also
shown
differ
result
may
attribut
differ
experiment
design
diseaseand
anim
model
use
studi
well
possibl
secret
inhibit
chemotact
cytokin
examin
furthermor
though
prcvlp
model
respiratori
diseas
quit
reproduc
long
use
laboratori
repres
complex
model
virusbacteri
diseas
mani
aspect
pathogen
mechan
even
singl
agent
yet
well
elucid
mechan
combin
pathogen
agent
even
less
well
understood
conclus
studi
demonstr
intratrach
administr
etanercept
abl
success
block
activ
vivo
lung
prcvlp
inocul
pig
first
hpi
reduct
howev
associ
decreas
diseas
sever
bronchoalveolar
neutrophil
infiltr
alter
viru
replic
induct
lung
obviou
differ
macroscop
lung
lesion
histopatholog
find
lung
data
confirm
gener
accept
belief
though
import
sole
culprit
develop
respiratori
diseas
patholog
possibl
yet
unidentifi
compon
mechan
immun
system
involv
complic
respiratori
viral
infect
secondari
bacteri
infect
vice
versa
commonli
found
field
condit
anim
human
yet
experiment
studi
complex
diseas
still
rare
rel
difficult
reproduc
therefor
studi
import
addit
gener
knowledg
complex
virusbacteri
infect
pathogen
mechan
though
exact
mechan
remain
still
obscur
